Crewe Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-300
| Closed | -$11.8K | – | 724 |
|
|
2024
Q4 | $11.8K | Sell |
300
-100
| -25% | -$3.94K | ﹤0.01% | 413 |
|
|
2024
Q3 | $18.8K | Buy |
400
+100
| +33% | +$4.7K | ﹤0.01% | 413 |
|
|
2024
Q2 | $16.2K | Buy |
300
+100
| +50% | +$5.4K | ﹤0.01% | 591 |
|
|
2024
Q1 | $13.6K | Buy |
+200
| New | +$13.6K | ﹤0.01% | 571 |
|